• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human IGLV1-51 Polyclonal Antibody

The antibody against IGLV1-51 was raised in rabbit using the Synthetic peptide of Human Lambda Light chain as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.

ADC-27670A

The antibody against IGLV1-51 was raised in rabbit using the Synthetic peptide of Human Lambda Light chain as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-27670A ClonalityPolyclonal
Host SpeciesRabbitTarget NameIGLV1-51
FormLiquidSpecies ReactivityHuman
IsotypeIgGStorage Buffer0.05% NaN3, 40% Glycerol., pH7.4 PBS
Purification MethodAntigen affinity purifiedConjugateNon-conjugated
ApplicationELISA, IHC, WBStorageUpon receipt

Immunogen Information


Immunogen DescriptionSynthetic peptide of Human Lambda Light chainTarget SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDP01701
Background Information
  • Uniprot Id

    P01701

  • Target Species

    Human

  • Target Name

    IGLV1-51

  • Target Full Name

    Immunoglobulin lambda variable 1-51

  • Target Function

    V region of the variable domain of immunoglobulin light chains that participates in the antigen recognition. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.

  • Target Subcellular Location

    Secreted. Cell membrane.

  • Target Synonyms

    IGLV1-51Immunoglobulin lambda variable 1-51; Ig lambda chain V-I region BL2; Ig lambda chain V-I region EPS; Ig lambda chain V-I region NEW; Ig lambda chain V-I region NIG-64

  • Target Background

    Predicted to be involved in immune response. Located in extracellular exosome.

Inquire Rabbit anti-Human IGLV1-51 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification